Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis

A. Busca, I. Cavecchia, F. Locatelli, S. D' Ardia, F.G. De Rosa, F. Marmont, G. Ciccone, I. Baldi, R. Serra, E. Gaido, M. Falda. Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis 2011. All rights reserved

[1]  L. Corey,et al.  The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation , 2010, Bone Marrow Transplantation.

[2]  M. Battegay,et al.  Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation , 2010, Bone Marrow Transplantation.

[3]  C. Viscoli,et al.  Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  P. Wayne.  PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .

[5]  L. Leibovici,et al.  Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients , 2007 .

[6]  G. Hobbs,et al.  The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit , 2007, Bone Marrow Transplantation.

[7]  H Rüden,et al.  Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation , 2007, Bone Marrow Transplantation.

[8]  L. Price,et al.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality , 2006, Bone Marrow Transplantation.

[9]  J. Sierra,et al.  Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  H. Einsele,et al.  Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time , 2005, Bone Marrow Transplantation.

[11]  L. Lanthier,et al.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Y. Kanda,et al.  Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  S. Zinner.  Fluoroquinolone prophylaxis in patients with neutropenia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  H. Döhner,et al.  Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  G. Papanicolaou,et al.  Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients , 2005, Transplant infectious disease : an official journal of the Transplantation Society.

[16]  F. Marco,et al.  Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000 , 2004, Annals of Hematology.

[17]  R. Ramphal,et al.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  P. Moreau,et al.  Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[20]  D. Engelhard,et al.  Nosocomial Colonization, Septicemia, and Ilickman/Broviac Catheter‐Related Infections in Bone Marrow Transplant Recipients: A 5‐Year Prospective Study , 1998, Medicine.